Scholarlink

<p>Ten novel coumarin-based hybrids comprising coumarin–pyrazole (<b>7a–e</b>) and coumarin–quinoline (<b>11a–e</b>) derivatives were synthesized via multistep reactions and characterized spectroscopically. Solvent optimization identified DMF: Ethanol (1:1) with H<sub>2</sub>SO<sub>4</sub> as optimal conditions, achieving 88% yield in 2–3&#xa0;h. Antimicrobial evaluation against four bacterial strains (<i>Bacillus subtilis</i>, <i>Staphylococcus aureus</i>, <i>Escherichia coli</i>, <i>Acinetobacter baumannii</i>) and one fungal strain (<i>Aspergillus niger</i>) revealed compound <b>7a</b> as the most potent (MIC: 25&#xa0;μg/mL), superior to standard drugs. Antioxidant screening showed that <b>7a</b> exhibited excellent activity (IC<sub>50</sub>: 20.23 ± 0.29&#xa0;mg/mL), comparable to that of ascorbic acid. Molecular docking against three target proteins (4WMZ, 5FNR, 4LOL) demonstrated strong binding affinity, with <b>7b</b> showing the highest docking score (− 9.71186&#xa0;kcal/mol) against 4WMZ. Notably, compound <b>7b</b> showed the highest predicted binding affinity in silico, whereas compound <b>7a</b> demonstrated the superior experimental antimicrobial activity; this discrepancy underscores that docking scores offer predictive, not confirmatory, evidence of biological potency. DFT calculations (B3LYP/6–311++ G(d,p)) elucidated electronic properties, including HOMO–LUMO gap (3.8640&#xa0;eV), Mulliken charge distribution, RDG, ELF, LOL, thermodynamic parameters, and global reactivity descriptors. In silico ADMET profiling revealed favorable physicochemical and drug-like properties for most derivatives; however, uniformly high predicted genotoxicity scores (&gt; 0.99) and moderate hERG cardiotoxicity liability were identified, highlighting the need for rigorous experimental safety validation prior to further development. This integrated approach establishes coumarin–pyrazole and coumarin–quinoline hybrids as promising multifunctional therapeutic agents with antimicrobial and antioxidant potential.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

In silico DFT, ADMET and molecular docking studies of novel coumarin-linked pyrazole and quinoline derivatives as antimicrobial and antioxidant agents

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月27日

查看全文
  • Nargis H. Shaikh,
  • Jay B. Maheta,
  • Darshna K. Lakhnotra,
  • Prince A. Dave,
  • Ila M. Ram,
  • Dharmesh N. Sherathia,
  • Dharmesh K. Katariya,
  • Hardik B. Bhatt,
  • Yogesh O. Bhola,
  • Swanti A. Jain

摘要

Ten novel coumarin-based hybrids comprising coumarin–pyrazole (7a–e) and coumarin–quinoline (11a–e) derivatives were synthesized via multistep reactions and characterized spectroscopically. Solvent optimization identified DMF: Ethanol (1:1) with H2SO4 as optimal conditions, achieving 88% yield in 2–3 h. Antimicrobial evaluation against four bacterial strains (Bacillus subtilis, Staphylococcus aureus, Escherichia coli, Acinetobacter baumannii) and one fungal strain (Aspergillus niger) revealed compound 7a as the most potent (MIC: 25 μg/mL), superior to standard drugs. Antioxidant screening showed that 7a exhibited excellent activity (IC50: 20.23 ± 0.29 mg/mL), comparable to that of ascorbic acid. Molecular docking against three target proteins (4WMZ, 5FNR, 4LOL) demonstrated strong binding affinity, with 7b showing the highest docking score (− 9.71186 kcal/mol) against 4WMZ. Notably, compound 7b showed the highest predicted binding affinity in silico, whereas compound 7a demonstrated the superior experimental antimicrobial activity; this discrepancy underscores that docking scores offer predictive, not confirmatory, evidence of biological potency. DFT calculations (B3LYP/6–311++ G(d,p)) elucidated electronic properties, including HOMO–LUMO gap (3.8640 eV), Mulliken charge distribution, RDG, ELF, LOL, thermodynamic parameters, and global reactivity descriptors. In silico ADMET profiling revealed favorable physicochemical and drug-like properties for most derivatives; however, uniformly high predicted genotoxicity scores (> 0.99) and moderate hERG cardiotoxicity liability were identified, highlighting the need for rigorous experimental safety validation prior to further development. This integrated approach establishes coumarin–pyrazole and coumarin–quinoline hybrids as promising multifunctional therapeutic agents with antimicrobial and antioxidant potential.